TargImmune Therapeutics AG
ActiveLimited or Corporation749100 - Patent brokering and marketing service activitiestargimmune.com
Biotechnology / Pharmaceutical ManufacturingCancer patients (via partnerships and clinical applications) and potential investors/pharmaceutical partners.
TargImmune Therapeutics AG is a Swiss AG registered in Basel, BS. Its registered activity falls under Patent brokering and marketing service activities.
AI-enriched data· marks AI-enriched fields
AI Insight
Registry narrative generated from SHAB/SOGC facts.
Employees~Approximately 20 employeesRevenue$5M USD annuallyOfficers22Active Relations4Deleted Relations0SOGC Records28First Record09.02.2016Latest Activity12.06.2026BiotechnologyOncologyImmunotherapyBaselCancer TreatmentNanoparticlesRNA Technology
Registry Information
- Swiss UID
- CHE-349.430.797
- Legal Name
- TargImmune Therapeutics AG
- Legal Form
- Limited or Corporation
- Incorporated
- 9 Feb 2016
- Share Capital
- CHF 2'136'978.40
- Canton
- BS
- Status
- Active
- Country
- Switzerland
Company Purpose
Translating…
NOGA Codes
(Industry classification)Patent brokering and marketing service activities
NPROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES74Other professional, scientific and technical activities749Other professional, scientific and technical activities n.e.c.7491Patent brokering and marketing service activities749100
Industry Health
Registered Address
St. Alban-Anlage 70
4052, Basel, BS
Companies at this address
Enrich from integrations
Pull data from your connected providers and merge it with the registry.
Registry Pulse
Registry pulse is a Pro feature
Current Directors & Officers
From the web
Target Customers
Cancer patients (via partnerships and clinical applications) and potential investors/pharmaceutical partners.
Competitors (1)
Various industry competitors
Biotech and pharmaceutical companies including Pelican Expression Technology, PharmEnable, Extend Biosciences, DeNovo Biopharma, Kite Pharma, T3 Pharma, Virometix, Ionctura, Nouscom, Tolremo, Anaveon, Numab, Bluebird Bio, Amphivena, Viratherapeutics, and NexImmune.
Sources (6)
Media & Investors - TargImmune
targimmune.com
TargImmune Therapeutics AG
targimmune.com
TargImmune Therapeutics AG · Mercury-Reports
mercury-reports.com
TargImmune Therapeutics AG | S-GE
s-ge.com
TargImmune Therapeutics AG - StückiPark
stueckipark.ch
TargImmune Therapeutics: Company Profile & Ownership | Mergr
mergr.com